Mirati Therapeutics, Inc. Annual Depreciation in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Mirati Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2012 to 2022.
  • Mirati Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $629K, a 114% increase year-over-year.
  • Mirati Therapeutics, Inc. annual Depreciation for 2022 was $2.8M, a 55.6% increase from 2021.
  • Mirati Therapeutics, Inc. annual Depreciation for 2021 was $1.8M, a 200% increase from 2020.
  • Mirati Therapeutics, Inc. annual Depreciation for 2020 was $600K, a 141% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.8M +$1M +55.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $1.8M +$1.2M +200% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $600K +$351K +141% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $249K +$74K +42.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $175K -$9K -4.89% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $184K +$4K +2.22% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $180K -$32K -15.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $212K +$13K +6.53% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $199K +$28K +16.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $171K +$48K +39% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 $123K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.